The levels of SMN-FL and SMNdelta7 protein and the corresponding mRNA (processed and pre-processed) in different cells and tissues, in healthy individuals and in individuals affected by SMA, are still largely undetermined in humans for obvious ethical issues. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.